For news and updates follow us on Twitter
The Coronavirus pandemic has had a profound impact on many people’s physical health around the world, including in the UK, but how can we measure its effect on people’s mental health?
In response to COVID-19 infection rates our research to investigate this important issue has restarted.
Renal researchers at NUH are the first in Europe to successfully offer patients a new treatment for a rare kidney disease which affects just 100 people in Nottingamshire.
Working in Respiratory Medicine at NUH, Mina Fatemi is on the frontline of COVID-19 clinical research. Her determination to find effective treatments for Coronavirus is one of the reasons that Mina is now embarking on a prestigious Florence Nightingale Windrush Leadership Programme.
Our clinical researchers are used to the sweet smell of success as their world-beating research is changing the lives of thousands of patients.
But now they are seeking an altogether more pungent odour as they ask their NUH colleagues to take part in testing whether medical detection dogs can be used to help identify COVID-19 in patients at the earliest stage of the infection, before symptoms occur or in cases where patients do not have any symptoms.
To what extent has COVID-19 had a psychological – or other – impact on patients living with advanced lung cancer?
Researchers at Nottingham University Hospitals have joined their colleagues at another six hospitals to find out, as part of the DIScOVER trial.
Physiotherapist Vicky Booth is one of just 30 people to receive a prestigious national Clinical Lectureship award. Here she talks about her career in research and the increasingly important roles that Allied Health Professionals like her are making to new discoveries in diseases such as Dementia.
Over 14,000 patients and almost £26 million of investment have again made NUH one of the top hospitals in the country for clinical research.
Tens of thousands of children who suffer from painful constipation will soon be offered a better way of diagnosing and managing their condition, thanks to a new agreement struck between Nottingham University Hospitals NHS Trust (NUH) and JEB Technologies, a specialist medical device manufacturing company.
Nottingham experts in liver disease are part of an international team of scientists behind a breakthrough in understanding why some medications cause drug-induced liver injury (DILI).
Specialists in Nottingham have been at the forefront of the development of cochlear implantation to enable deaf patients to hear for many years. Now, with their input, worldwide guidelines on access to cochlear implants have been published for the first time.